Case No
|
Pathology
|
CK
|
EMA
|
NSE
|
Syn
|
CgA
|
CD56
|
S-100
|
TTF-1
|
---|
1
|
SCC
|
++
|
+++
|
+++
|
+++
|
++
|
+++
|
-
|
+++
|
2
|
SCC
|
+++
|
++
|
+
|
++
|
-
|
+
|
-
|
-
|
3
|
SCC
|
++
|
+++
|
++
|
+++
|
+
|
+++
|
-
|
++
|
4
|
SCC
|
+++
|
++
|
++
|
++
|
++
|
++
|
++
|
+++
|
5
|
SCC
|
++
|
+++
|
-
|
+
|
-
|
+++
| |
-
|
6
|
SCC
|
++
|
++
|
+
|
+++
|
++
|
++
|
-
|
+++
|
7
|
SCC
|
+++
|
++
|
+
|
++
|
+
|
+++
|
+
|
++
|
8
|
SCC
|
+++
|
++
|
+++
|
++
|
-
|
+++
|
-
|
++
|
9
|
SCC
|
-
|
-
|
+++
|
+++
|
++
|
+++
|
++
|
+++
|
|
SqCC
|
+++
|
++
|
-
|
-
|
-
|
-
|
-
|
-
|
10
|
SCC
|
-
|
+
|
+
|
+++
|
+++
|
-
|
-
|
++
|
11
|
SCC
|
-
|
-
|
-
|
++
|
-
|
++
|
-
|
-
|
12
|
SCC
|
-
|
-
|
-
|
++
|
-
|
-
|
-
|
+
|
13
|
SCC
|
-
|
-
|
++
|
+++
|
++
|
+++
|
-
|
-
|
14
|
SCC
|
++
|
-
|
+
|
+++
|
++
|
++
|
-
|
+++
|
15
|
SCC
|
+
|
++
|
-
|
++
|
++
|
+++
|
-
|
++
|
16
|
SCC
|
-
|
-
|
-
|
++
|
-
|
-
|
-
|
++
|
17
|
SCC
|
++
|
+++
|
++
|
+++
|
+
|
+++
|
+
|
-
|
18
|
SCC
|
-
|
++
|
-
|
-
|
++
|
-
|
-
|
+++
|
19
|
SCC
|
++
|
++
|
-
|
++
|
-
|
+++
|
-
|
-
|
20
|
SCC
|
-
|
-
|
+
|
+++
|
-
|
++
|
-
|
++
|
21
|
SCC
|
-
|
-
|
-
|
+++
|
+++
|
-
|
-
|
++
|
|
SqCC
|
+++
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Total positive cases (%)
|
12(57.1)
|
13(61.9)
|
13(61.9)
|
20(95.2)
|
13(61.9)
|
16(76.2)
|
4(19.0)
|
15(71.4)
|
- SCC, small cell carcinoma; SqCC, squamous cell carcinoma. +, less than 10% of the tumor cells were positive; ++, 10%–50% of the tumor cells were positive; +++, more than 50% the tumor cells were positive; -, negative labeling.